Skip to Content

  • Search

View Additional Section Content

NRG BR003 A Randomized Phase III Trial of Adjuvant Therapy comparing Doxorubicin plus Cyclophosphamide followed by weekly Paclitaxel with or without Carboplatin for Node-Positive of High risk node negative triple negative invasive breast cancer.

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/record/NCT02488967?term=nrg-br003&rank=1

Clinical Trial Categories

  • Breast Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details